CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 51 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q3 2023. The put-call ratio across all filers is 0.08 and the average weighting 2.6%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 2,937,615 | $19,006,369 | 42.74% |
| Medicxi Ventures Management (Jersey) Ltd | 19,963,157 | $129,161,626 | 41.24% |
| Vida Ventures Advisors, LLC | 3,931,818 | $25,438,862 | 39.38% |
| TCG Crossover Management, LLC | 2,040,816 | $13,204,079 | 1.94% |
| Affinity Asset Advisors, LLC | 1,018,091 | $6,587,049 | 1.85% |
| BVF INC/IL | 9,103,054 | $58,896,759 | 1.59% |
| Sio Capital Management, LLC | 756,891 | $4,897,085 | 1.52% |
| ACUTA CAPITAL PARTNERS, LLC | 323,349 | $2,092,068 | 1.40% |
| EcoR1 Capital, LLC | 5,618,779 | $36,353,500 | 1.23% |
| GENERAL ATLANTIC, L.P. | 9,681,818 | $62,641,362 | 0.97% |
| Tanager Wealth Management LLP | 696,096 | $4,503,741 | 0.93% |
| Kynam Capital Management, LP | 730,472 | $4,726,154 | 0.77% |
| Octagon Capital Advisors LP | 475,600 | $3,077,132 | 0.47% |
| Boxer Capital, LLC | 770,708 | $4,986,481 | 0.26% |
| Cormorant Asset Management, LP | 561,600 | $3,633,552 | 0.21% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 337,544 | $2,183,910 | 0.08% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,830,500 | $18,313,335 | 0.04% |
| Point72 Asset Management, L.P. | 1,840,482 | $11,907,919 | 0.04% |
| Woodline Partners LP | 210,204 | $1,360,020 | 0.02% |
| FRANKLIN RESOURCES INC | 832,348 | $5,385,292 | 0.00% |
External links
This page lists CENTESSA PHARMACEUTICALS PLC's shareholders in Q3 2023. To view CENTESSA PHARMACEUTICALS PLC's shareholder history, click here.